Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Net Income towards Common Stockholders (2020 - 2025)

Historic Net Income towards Common Stockholders for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$7.6 million.

  • GeneDx Holdings' Net Income towards Common Stockholders rose 814.49% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 10249.55%. This contributed to the annual value of -$52.3 million for FY2024, which is 7025.27% up from last year.
  • Latest data reveals that GeneDx Holdings reported Net Income towards Common Stockholders of -$7.6 million as of Q3 2025, which was up 814.49% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Net Income towards Common Stockholders ranged from a high of $32.7 million in Q3 2021 and a low of -$308.7 million during Q4 2022
  • In the last 5 years, GeneDx Holdings' Net Income towards Common Stockholders had a median value of -$29.2 million in 2024 and averaged -$50.9 million.
  • Per our database at Business Quant, GeneDx Holdings' Net Income towards Common Stockholders skyrocketed by 15781.33% in 2021 and then plummeted by 75905.3% in 2022.
  • Over the past 5 years, GeneDx Holdings' Net Income towards Common Stockholders (Quarter) stood at -$40.2 million in 2021, then plummeted by 668.23% to -$308.7 million in 2022, then surged by 91.65% to -$25.8 million in 2023, then surged by 121.1% to $5.4 million in 2024, then tumbled by 240.4% to -$7.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$7.6 million for Q3 2025, versus $10.8 million for Q2 2025 and -$6.5 million for Q1 2025.